Division of Infectious Diseases

Epidemic Intelligence Service officers check the humidity and take samples from linens in a patient room while investigating a hospital-associated mucormycosis outbreak in Little Rock, Arkansas, in March 2021.
June 16, 2022

VUMC to pilot CDC joint training program

Vanderbilt University Medical Center is among 11 centers that will pilot a new federally sponsored training program, the Joint Infectious Diseases/Epidemic Intelligence Service (ID/EIS) Fellowship.

By Paul Govern
June 8, 2022

Dooley to lead Division of Infectious Diseases

Kelly Dooley, MD, PhD, MPH, has been appointed professor and Addison B. Scoville Jr. Chair in Medicine and director of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center, effective Sept. 12.

By Paul Govern
Rebecca (Ribka) Berhanu, MD
March 30, 2022

New Clinician Spotlight: Rebecca (Ribka) Berhanu

Rebecca Berhanu, MD, assistant professor of Medicine, has joined Vanderbilt’s Division of Infectious Diseases as a clinician and researcher.

By VUMC News and Communications
March 17, 2022

Blood test figures in cancer risk for people with HIV

A Vanderbilt study found that, among adult patients with HIV, those who have lower counts of certain types of blood cells have a markedly higher risk of developing cancer.

By Paul Govern
José Ontiveros, center, and his wife, Isela Morales, to his left, are surrounded by some of the team members who helped save his life as he battled post-COVID complications, including from left, infectious disease specialist Karen Bloch, MD, MPH; interpreter Eleazar Jimenez; orthopaedic surgeon Amir Abtahi, MD; infectious disease specialist Christina Fiske, MD, MPH; and otolaryngologist Sarah Rohde, MD, MMHC.
March 16, 2022

Teamwork returns man with severe post-COVID complications to his life

A multidisciplinary team at Vanderbilt helped José Ontiveros cope with a long list of severe complications arising from his COVID-19i infection.

By Jill Clendening
March 14, 2022

Microbiome reflects COVID-19 severity

Characterization of the upper respiratory tract microbiome could help predict outcomes for COVID-19 infection, Vanderbilt researchers have discovered.

By Elliot Jaffe 
February 28, 2022

Invasive strep can defy zinc toxicity

Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels.
By Taylor Engdahl
January 24, 2022

Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines

Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children.
By Jessica Pasley
January 17, 2022

H. pylori, lipid loss and stomach cancer

H. pylori infection — a strong risk factor for stomach cancer — changes the composition of stomach lipids, which could offer new biomarkers for detecting premalignant changes, Vanderbilt researchers discovered.
By Leigh MacMillan
January 3, 2022

Bloch, Haas appointed interim leaders of the Division of Infectious Diseases

Karen Bloch, MD, MPH, and David Haas, MD, have been appointed interim leaders of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center.
By Paul Govern
November 15, 2021

Who’s who in the respiratory landscape

A metatranscriptomics method developed by Vanderbilt researchers simultaneously characterizes viruses, microbiome and host response in nasal swabs, opening opportunities to explore molecular interactions directly in clinical samples.
By Leigh MacMillan
August 12, 2021

Wanjalla honored by Doris Duke Foundation

Celestine Wanjalla, MD, PhD, assistant professor of Medicine in the Division of Infectious Diseases, is among 17 recipients of the Doris Duke Charitable Foundation 2021 Clinical Scientist Development Award.
By Paul Govern
August 12, 2021

Certain drug exposures correlate with reduced COVID severity: study

Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked whether COVID disease severity correlated with any drugs that happened to be taken by these patients in the months leading up to their diagnosis.
By Paul Govern
1 2 3 4 5 6 … 13